242 related articles for article (PubMed ID: 32753597)
1. The Human LL-37(17-29) antimicrobial peptide reveals a functional supramolecular structure.
Engelberg Y; Landau M
Nat Commun; 2020 Aug; 11(1):3894. PubMed ID: 32753597
[TBL] [Abstract][Full Text] [Related]
2. The C-Terminal VPRTES Tail of LL-37 Influences the Mode of Attachment to a Lipid Bilayer and Antimicrobial Activity.
de Miguel Catalina A; Forbrig E; Kozuch J; Nehls C; Paulowski L; Gutsmann T; Hildebrandt P; Mroginski MA
Biochemistry; 2019 May; 58(19):2447-2462. PubMed ID: 31016971
[TBL] [Abstract][Full Text] [Related]
3. The amphibian antimicrobial peptide uperin 3.5 is a cross-α/cross-β chameleon functional amyloid.
Salinas N; Tayeb-Fligelman E; Sammito MD; Bloch D; Jelinek R; Noy D; Usón I; Landau M
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33431675
[TBL] [Abstract][Full Text] [Related]
4. Recombinant expression of human cathelicidin (hCAP18/LL-37) in Pichia pastoris.
Hong IP; Lee SJ; Kim YS; Choi SG
Biotechnol Lett; 2007 Jan; 29(1):73-8. PubMed ID: 17028774
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activities and structures of two linear cationic peptide families with various amphipathic beta-sheet and alpha-helical potentials.
Jin Y; Hammer J; Pate M; Zhang Y; Zhu F; Zmuda E; Blazyk J
Antimicrob Agents Chemother; 2005 Dec; 49(12):4957-64. PubMed ID: 16304158
[TBL] [Abstract][Full Text] [Related]
6. From Structure to Function: pH-Switchable Antimicrobial Nano-Self-Assemblies.
Gontsarik M; Yaghmur A; Ren Q; Maniura-Weber K; Salentinig S
ACS Appl Mater Interfaces; 2019 Jan; 11(3):2821-2829. PubMed ID: 30589253
[TBL] [Abstract][Full Text] [Related]
7. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity.
Oren Z; Lerman JC; Gudmundsson GH; Agerberth B; Shai Y
Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):501-13. PubMed ID: 10417311
[TBL] [Abstract][Full Text] [Related]
8. Interaction of LL-37 human cathelicidin peptide with a model microbial-like lipid membrane.
Majewska M; Zamlynny V; Pieta IS; Nowakowski R; Pieta P
Bioelectrochemistry; 2021 Oct; 141():107842. PubMed ID: 34049238
[TBL] [Abstract][Full Text] [Related]
9. RL-37, an alpha-helical antimicrobial peptide of the rhesus monkey.
Zhao C; Nguyen T; Boo LM; Hong T; Espiritu C; Orlov D; Wang W; Waring A; Lehrer RI
Antimicrob Agents Chemother; 2001 Oct; 45(10):2695-702. PubMed ID: 11557457
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional analysis of the pro-domain of human cathelicidin, LL-37.
Pazgier M; Ericksen B; Ling M; Toth E; Shi J; Li X; Galliher-Beckley A; Lan L; Zou G; Zhan C; Yuan W; Pozharski E; Lu W
Biochemistry; 2013 Mar; 52(9):1547-58. PubMed ID: 23406372
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37.
Henzler Wildman KA; Lee DK; Ramamoorthy A
Biochemistry; 2003 Jun; 42(21):6545-58. PubMed ID: 12767238
[TBL] [Abstract][Full Text] [Related]
12. Human antimicrobial peptides: defensins, cathelicidins and histatins.
De Smet K; Contreras R
Biotechnol Lett; 2005 Sep; 27(18):1337-47. PubMed ID: 16215847
[TBL] [Abstract][Full Text] [Related]
13. Structure and biology of cathelicidins.
Zanetti M; Gennaro R; Scocchi M; Skerlavaj B
Adv Exp Med Biol; 2000; 479():203-18. PubMed ID: 10897421
[No Abstract] [Full Text] [Related]
14. Structural remodeling and oligomerization of human cathelicidin on membranes suggest fibril-like structures as active species.
Sancho-Vaello E; François P; Bonetti EJ; Lilie H; Finger S; Gil-Ortiz F; Gil-Carton D; Zeth K
Sci Rep; 2017 Nov; 7(1):15371. PubMed ID: 29133814
[TBL] [Abstract][Full Text] [Related]
15. Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles.
Wang G
J Biol Chem; 2008 Nov; 283(47):32637-43. PubMed ID: 18818205
[TBL] [Abstract][Full Text] [Related]
16. Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin II.
Fox MA; Thwaite JE; Ulaeto DO; Atkins TP; Atkins HS
Peptides; 2012 Feb; 33(2):197-205. PubMed ID: 22289499
[TBL] [Abstract][Full Text] [Related]
17. Decoding the functional roles of cationic side chains of the major antimicrobial region of human cathelicidin LL-37.
Wang G; Epand RF; Mishra B; Lushnikova T; Thomas VC; Bayles KW; Epand RM
Antimicrob Agents Chemother; 2012 Feb; 56(2):845-56. PubMed ID: 22083479
[TBL] [Abstract][Full Text] [Related]
18. Hydramacin-1 in action: scrutinizing the barnacle model.
Michalek M; Vincent B; Podschun R; Grötzinger J; Bechinger B; Jung S
Antimicrob Agents Chemother; 2013 Jul; 57(7):2955-66. PubMed ID: 23587944
[TBL] [Abstract][Full Text] [Related]
19. Comparative mode of action of novel hybrid peptide CS-1a and its rearranged amphipathic analogue CS-2a.
Joshi S; Bisht GS; Rawat DS; Maiti S; Pasha S
FEBS J; 2012 Oct; 279(20):3776-90. PubMed ID: 22883393
[TBL] [Abstract][Full Text] [Related]
20. Rare by Natural Selection: Disulfide-Bonded Supramolecular Antimicrobial Peptides.
Engelberg Y; Ragonis-Bachar P; Landau M
Biomacromolecules; 2022 Mar; 23(3):926-936. PubMed ID: 35061360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
